Maternal and neonatal outcomes in women with a history of chemotherapy exposure: a population-based study of 8 million obstetric admissions.
10 May, 2022 | 10:38h | UTCMaternal and neonatal outcomes in women with a history of chemotherapy exposure: a population-based study of 8 million obstetric admissions – Archives of Gynecology and Obstetrics (link to abstract – $ for full-text)
Commentary on Twitter
May 7: Women with a history of chemotherapy were more likely to suffer from obstetric and medical complications including pre-eclampsia, chorioamnionitis, postpartum hemorrhage, and venous thromboembolism as well as an increased risk in overall mortality. https://t.co/FqC5HT52N9
— All Source Pregnancy (@PregnancyAll) May 8, 2022